Article citationsMore >>

Borghi, C., Cicero, A.F., “Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses,” Br J Clin Pharmacol, 83(1). 163-171. Jan.2017.

has been cited by the following article:

Article

Evaluation in Patients with High NORMAL Blood Pressure of a Supplement Containing Arginine, Lactobacillus Plantarum Lp-LDL, Coenzime Q10 and Vitamin B1: A PILOT Study

1Department of Internal Medicine and Therapeutics, University of Pavia, PAVIA, Italy

2Laboratory of Molecular Medicine, University of Pavia, PAVIA, Italy;Responsible Diabetes Area of Italian Nutraceutical Society (SINut)

3Internal Medicine Division, Ospedale Angelo Bellini, Somma Lombardo, VARESE, Italy

4Laboratory of Molecular Medicine, University of Pavia, PAVIA, Italy


Journal of Food and Nutrition Research. 2020, Vol. 8 No. 6, 273-278
DOI: 10.12691/jfnr-8-6-5
Copyright © 2020 Science and Education Publishing

Cite this paper:
Giuseppe Derosa, Giovanni Gaudio, Angela D’Angelo, Pamela Maffioli. Evaluation in Patients with High NORMAL Blood Pressure of a Supplement Containing Arginine, Lactobacillus Plantarum Lp-LDL, Coenzime Q10 and Vitamin B1: A PILOT Study. Journal of Food and Nutrition Research. 2020; 8(6):273-278. doi: 10.12691/jfnr-8-6-5.

Correspondence to: Giuseppe  Derosa, Department of Internal Medicine and Therapeutics, University of Pavia, PAVIA, Italy. Email: giuseppe.derosa@unipv.it

Abstract

Aim: to evaluate the effects of a nutraceutical containing Arginine, Lactobacillus Plantarum Lp-LDL, Coenzyme Q10 and Vitamin B1 in patients with high normal blood pressure on the levels of systolic (SBP) and diastolic blood pressure (DBP). Methods: we enrolled 40 patients of both sexes, with high normal pressure (SBP values between 130-139 mmHg and/or DBP between 85-89 mmHg) according to the 2018 ESC/ESH Guidelines for the management of arterial hypertension. Patients were consecutively enrolled to take nutraceutical for 3 months and it is self-administered once a day during the breakfast. Results: no significant variations of BMI or circumferences were recorded with nutraceutical from baseline. A slight reduction of FPG was recorded, although this variation was not significant. Significant reductions were obtained in SBP (p< 0.05) and DBP (p< 0.05). No significant HR variation was observed from baseline. A significant TC and LDL-C decrease were observed after 3 months (p< 0.05, respectively). No significant HDL-C, and Tg variations were obtained after 3 months. No significant reduction of Hs-CRP was recorded compared to baseline. No significant variations of transaminases were recorded during the study, and creatinine value was not significantly modified compared to baseline. Conclusions: a nutraceutical containing Arginine, Lactobacillus Plantarum Lp-LDL, Coenzyme Q10 and Vitamin B1 could be helpful in improving high normal blood pressure, and hypercholesterolemia, two of the major risk factors for vascular events.

Keywords